SCHEMBL460240

SCHEMBL460240

COc1ncc(-c2nn3cc(-c4ccncc4)nc3s2)cc1N

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.55
TTK P33981 1/20 0.55
AURKB Q96GD4 1/20 0.55
INCENP Q9NQS7 1/20 0.55
CA12 O43570 7/20 0.47
CA1 P00915 7/20 0.47
CA2 P00918 7/20 0.47
CA9 Q16790 7/20 0.47
TP53 P04637 2/20 0.46
F2RL3 Q96RI0 9/20 0.43
MAPT P10636 2/20 0.41
CASP1 P29466 1/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL453667 0.81 MAPT (0.43) AURKATTKAURKBINCENPCA12
SCHEMBL460239 0.79 AURKA (0.59) AURKATTKAURKBINCENPMAPT
SCHEMBL452519 0.75 PIK3CA (0.59)
SCHEMBL2684595 0.73 AURKA (1.00) AURKATTKAURKBINCENPMAPT
SCHEMBL453666 0.69 MAPT (0.45) AURKATTKAURKBINCENPMAPT
SCHEMBL2123352 0.69 PIK3CA (0.70) CA12CA1CA2CA9F2RL3
SCHEMBL532339 0.68 PIK3CA (0.70) CA12CA1CA2CA9TP53
SCHEMBL532634 0.67 KDM4E (0.62) CA12CA1CA2CA9TP53
SCHEMBL2123324 0.67 PIK3CA (0.70) CA12CA1CA2CA9TP53
SCHEMBL532292 0.67 PIK3CA (0.46) TP53F2RL3MAPTMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011121317-A9 IMIDAZOTHIADIAZOLES FOR USE AS KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS (CNIO) (ES) 2012-03-15 WO disclosed
WO-2011121317-A1 IMIDAZO [2,1-B] [1,3,4] THIADIAZOLES AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS (CNIO) (ES) 2011-10-06 WO disclosed